Incyte

-$0.85 (-1.28%) Today
-$0.11 (-0.17%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib).

CEO
Herve Hoppenot
Employees
1,773
Headquarters
Wilmington, Delaware
Founded
1991

INCY Key Statistics

Market cap
14.53B
Price-Earnings ratio
27.66
Dividend yield
—
Average volume
2.85M
High today
$66.79
Low today
$65.21
Open price
$66.79
Volume
2.13M
52 Week high
$101.47
52 Week low
$61.91

INCY Earnings

-$2.86
-$1.49
-$0.13
$1.24
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure